Indications:
● Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis: Vimovo relieves the signs and symptoms of arthritis, reducing inflammation, stiffness, and joint pain.
● Prevention of Gastric Ulcers: It is prescribed for patients at risk of developing NSAID-associated gastric ulcers, particularly useful for those requiring prolonged NSAID treatment.
Administration Guidelines
Dosage:
● The typical starting dose for Vimovo is one tablet taken twice daily, at least 30 minutes before meals. The dosage may vary based on the patient’s medical condition, treatment response, and other medications they may be taking.
Method of Administration:
● Oral: Vimovo is administered orally in tablet form. The tablets should be swallowed whole with water and not split or chewed. or crushed to avoid damaging the enteric coating designed to prevent premature drug release.
Dosage Form:
● Oral tablets (combination of Naproxen and Esomeprazole)
Safety Preclusions
Pregnancy and Breastfeeding:
● The use of Vimovo is typically not recommended during pregnancy, particularly in the later stages, due to potential risks to the developing fetus. Women of childbearing age should use effective birth control to prevent pregnancy during treatment. The decision to use Vimovo during breastfeeding should be made only after considering the benefits and risks.
Drug Interactions:
● Vimovo can interact with several other medications, which may require dose adjustment or special monitoring. It is especially important to note interactions with blood thinners, other NSAIDs, certain antidepressants, and drugs that affect stomach acid levels.
|
